Journal Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rather Than Prescribing - How About Deprescribing? Providing Safe Care for Patients Lost in the Maze of Polypharmacy
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0324Published: Mar/Apr 2024Expires: 6/6/2025DetailsRequired Passing Score: 8/10 (80%)Categories: Advanced Practice Nursing , Drug TherapySpecialties: Advanced Practice Nursing, Primary CareTopics: Deprescribing , PolypharmacyMedia: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} ZURZUVAE - The First Oral Treatment Approved for Postpartum Depression
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0124Published: Jan/Feb 2024Expires: 3/7/2025DetailsRequired Passing Score: 8/10 (80%)Categories: Advanced Practice Nursing , Drug Therapy , Gynecological , Obstetrics , Psychosocial/Psychiatric , Women's HealthSpecialties: Advanced Practice Nursing, Gynecology, Maternal-Child, OB/GYN, Obstetrics, Psychiatric and Mental Health, Women's HealthMedia: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Nonhormonal Selective NK3R Antagonist for Moderate to Severe Vasomotor Symptoms in Menopause
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS1123Published: Nov/Dec 2023Expires: 12/6/2024DetailsRequired Passing Score: 7/10 (70%)Topics: Gynecologic , Hormone Therapy , Menopause , Nonhormonal Selective Neurokinin-3 Receptor Antagonist , Vasomotor SymptomsMedia: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rising Xylazine Drug Abuse in Humans: A Deep and Lingering High With Wounds, Amputations, and Death
Price: $17.95Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0723Published: Jul/Aug 2023Expires: 6/6/2025DetailsRequired Passing Score: 7/10 (70%)Categories: Addiction , Advanced Practice NursingSpecialties: Addiction, Advanced Practice NursingTopics: Xylazine -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Food and Drug Administration Accelerated Approval of Lecanemab for Early Alzheimer's Disease - Hope, Reality, and the Unknown Going Forward
Price: $17.95Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0523Published: May/Jun 2023Expires: 6/6/2025DetailsRequired Passing Score: 8/10 (80%)Topics: Alzheimer Disease , Drug Update -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} So Where is a Vaccine for Respiratory Syncytial Virus?
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0323Published: Mar/Apr 2023Expires: 3/7/2025DetailsRequired Passing Score: 8/10 (80%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Antiviral Considerations for Monkeypox Infection - USE CAUTION!
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0123Published: Jan/Feb 2023Expires: 3/7/2025DetailsRequired Passing Score: 8/10 (80%)Specialties: Advanced Practice Nursing, Infectious Diseases -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Another Outbreak! Monkeypox 2022 Infection and Vaccine Considerations for the Clinical Nurse Specialist
Price: $21.95Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS1122Published: Nov/Dec 2022Expires: 12/6/2024DetailsRequired Passing Score: 8/10 (80%)Categories: Advanced Practice Nursing , InfectionSpecialties: Advanced Practice Nursing, Community Health, Infectious Diseases, Primary Care, Public HealthTopics: Monkeypox (Mpox) , Vaccinations -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Another Outcome of the COVID-19 Pandemic: The Possible Repurposing of Selective Serotonin Reuptake Inhibitors
Price: $21.95Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0922Published: Sep/Oct 2022Expires: 9/6/2024DetailsRequired Passing Score: 8/10 (80%)Categories: ResearchSpecialties: Advanced Practice Nursing, Research -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Teprotumumab, a Human Monoclonal Antibody Insulin-like Growth Factor-1 Receptor Inhibitor for Thyroid Eye Disease
Price: $21.95Credits:
- ANCC 2.0 CH / 1.0 APH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0522Published: May/Jun 2022Expires: 3/7/2025DetailsRequired Passing Score: 8/10 (80%)Categories: Advanced Pharmacology Hours , Advanced Practice Nursing , Diabetes & Endocrine , Drug Therapy , Immunology/Allergy , Medical-Surgical , Ophthalmology